NASDAQ:ANTX | Balance Sheet | AN2 Therapeutics, Inc.

Complete source-backed balance-sheet history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$44.32M$79.99M$216,000.00$81.68M$1.97M$5.59M$170,000.00$5.76M$75.92M
2026-03-31$53.49M$87.49M$87.49M$2.62M$5.56M$170,000.00$5.73M$81.76M
2025-12-31$19.94M$59.94M$0.00$61.95M$3.02M$8.72M$170,000.00$8.89M$53.06M
2025-09-30$18M$64.02M$0.00$67.24M$2.23M$6.86M$60.38M
2025-06-30$18.22M$67.52M$0.00$75.83M$2.11M$6.98M$68.84M
2025-03-31$19.99M$69.56M$304,000.00$81.34M$3.07M$8.01M$73.33M
2024-12-31$21.35M$86.26M$804,000.00$92.09M$3.32M$10.24M$0.00$10.24M$81.85M
2024-09-30$33.5M$97.69M$97.69M$1.71M$10.02M$10.02M$87.67M
2024-06-30$26.77M$107.44M$1.04M$108.48M$1.89M$10.13M$98.35M
2024-03-31$24.69M$116.31M$1.04M$121.26M$2.43M$10.66M$110.6M
2023-12-31$15.65M$110.51M$1.04M$138.74M$2.68M$14.04M$14.04M$124.7M
2023-09-30$32.62M$126.41M$1.04M$153.81M$4.88M$14.84M$14.84M$138.97M
2023-06-30$40.81M$98.21M$720,000.00$98.93M$3.13M$11.16M$11.16M$87.76M
2023-03-31$26.71M$90.32M$720,000.00$91.08M$3.55M$8.57M$8.57M$82.52M
2022-12-31$27.22M$98.62M$720,000.00$102.56M$2.12M$7.19M$7.19M$95.37M
2022-09-30$28.8M$107.3M$720,000.00$110.01M$1.44M$4.43M$4.44M$105.57M
2022-06-30$40.62M$116.88M$720,000.00$120.02M$1.61M$4.15M$4.15M$115.86M
2022-03-31$82.52M$119.78M$720,000.00$120.5M$2.61M$5.09M$5.09M$115.41M
2021-12-31$12.1M$60.11M$65.32M$1.06M$3.4M$3.41M-$47.41M
2021-09-30$15.81M-$38.35M
2021-06-30$27.73M-$29.84M
2021-03-31$82.27M-$23.11M
2020-12-31$4.07M-$20.32M